| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Dipartimento di Medicina Clinica e Sperimentale, Clinica di Gastroenterologia ed Epatologia; Università degli Studi di Perugia;
Dipartimento di Farmacologia, Universita’ di Napoli, Italy;
Dipartimento di Medicina Interna, Universita’ di Messina; and
§
NicOx, Sophia Antipolis, France
Caspase-1, the IL-1ß converting enzyme (ICE), is required for
intracellular processing/maturation of IL-1ß and IL-18. NO releasing
nonsteroidal antiinflammatory drugs (NSAIDs) are a new class of NSAID
derivatives that spare the gastric mucosa. Here, we tested the
hypothesis that NCX-4016, a NO-aspirin derivative, inhibits
proinflammatory cytokine release from endotoxin (LPS)-challenged
monocytes. Our results demonstrated that exposing LPS-stimulated human
monocytes to NCX-4016 resulted in a 40–80% inhibition of IL-1ß,
IL-8, IL-12, IL-18, IFN-
, and TNF-
release with an
EC50 of 10–20 µM for IL-1ß and IL-18. Incubating
LPS-primed monocytes with NCX-4016 resulted in intracellular NO
formation as assessed by measuring nitrite/nitrate, intracellular cGMP
concentration, and intracellular NO formation. Exposing LPS-stimulated
monocytes to aspirin or celecoxib caused a 90% inhibition of
prostaglandin E2 generation but had no effect on cytokine
release. NCX-4016, similar to the NO donor
S-nitroso-N-acetyl-D-L-penicillamine,
inhibited caspase-1 activity with an EC50 of 
20 µM.
The inhibition of caspase-1 by NCX-4016 was reversible by the addition
of DTT, which is consistent with S-nitrosylation as the
mechanism of caspase-1 inhibition. NCX-4016, but not aspirin, prevented
ICE activation as measured by assessing the release of ICE p20 subunit.
IL-18 immunoneutralization resulted in a 60–80% reduction of IL-1ß,
IL-8, IFN-, and TNF- release from LPS-stimulated monocytes. Taken
together, these data indicate that incubating human monocytes with
NCX-4016 causes intracellular NO formation and suppresses IL-1ß and
IL-18 processing by inhibiting caspase-1 activity. Caspase-1 inhibition
is a new, cycloxygenase-independent antiinflammatory mechanism of
NO-aspirin.
This article has been cited by other articles:
|
|
 |
|
  J. Hewinson, S. F. Moore, C. Glover, A. G. Watts, and A. B. MacKenzie A Key Role for Redox Signaling in Rapid P2X7 Receptor-Induced IL-1{beta} Processing in Human Monocytes J. Immunol., June 15, 2008; 180(12): 8410 - 8420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Gladwin and G. J. Kato Hemolysis-associated hypercoagulability in sickle cell disease: the plot (and blood) thickens! Haematologica, January 1, 2008; 93(1): 1 - 3. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bratasz, N. M. Weir, N. L. Parinandi, J. L. Zweier, R. Sridhar, L. J. Ignarro, and P. Kuppusamy Reversal to cisplatin sensitivity in recurrent human ovarian cancer cells by NCX-4016, a nitro derivative of aspirin PNAS, March 7, 2006; 103(10): 3914 - 3919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. De Santo, P. Serafini, I. Marigo, L. Dolcetti, M. Bolla, P. Del Soldato, C. Melani, C. Guiducci, M. P. Colombo, M. Iezzi, et al. Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination PNAS, March 15, 2005; 102(11): 4185 - 4190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Emanueli, S. Van Linthout, M. B. Salis, A. Monopoli, P. Del Soldato, E. Ongini, and P. Madeddu Nitric Oxide-Releasing Aspirin Derivative, NCX 4016, Promotes Reparative Angiogenesis and Prevents Apoptosis and Oxidative Stress in a Mouse Model of Peripheral Ischemia Arterioscler Thromb Vasc Biol, November 1, 2004; 24(11): 2082 - 2087. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Wallace, G. Rizzo, G. Cirino, P. Del Soldato, and S. Fiorucci Enhanced Anti-Inflammatory Potency of a Nitric Oxide-Releasing Derivative of Flunisolide: Role of Nuclear Factor-{kappa}B J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 1096 - 1102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Fiorucci, A. Mencarelli, A. Meneguzzi, A. Lechi, B. Renga, P. del Soldato, A. Morelli, and P. Minuz Co-administration of nitric oxide-aspirin (NCX-4016) and aspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans J. Am. Coll. Cardiol., August 4, 2004; 44(3): 635 - 641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fiorucci, A. Mencarelli, E. Distrutti, M. Baldoni, P. del Soldato, and A. Morelli Nitric Oxide Regulates Immune Cell Bioenergetic: A Mechanism to Understand Immunomodulatory Functions of Nitric Oxide-Releasing Anti-Inflammatory Drugs J. Immunol., July 15, 2004; 173(2): 874 - 882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fiorucci, E. Distrutti, A. Mencarelli, G. Rizzo, A. R. D. Lorenzo, M. Baldoni, P. del Soldato, A. Morelli, and J. L. Wallace Cooperation between Aspirin-Triggered Lipoxin and Nitric Oxide (NO) Mediates Antiadhesive Properties of 2-(Acetyloxy)benzoic Acid 3-(Nitrooxymethyl)phenyl Ester (NCX-4016) (NO-Aspirin) on Neutrophil-Endothelial Cell Adherence J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1174 - 1182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Williams, N. Nath, J. Chen, T. R. Hundley, J. Gao, L. Kopelovich, K. Kashfi, and B. Rigas Growth Inhibition of Human Colon Cancer Cells by Nitric Oxide (NO)-Donating Aspirin Is Associated with Cyclooxygenase-2 Induction and {beta}-Catenin/T-Cell Factor Signaling, Nuclear Factor-{kappa}B, and NO Synthase 2 Inhibition: Implications for Chemoprevention Cancer Res., November 15, 2003; 63(22): 7613 - 7618. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Fiorucci, A. Mencarelli, A. Meneguzzi, A. Lechi, A. Morelli, P. del Soldato, and P. Minuz NCX-4016 (NO-Aspirin) Inhibits Lipopolysaccharide-Induced Tissue Factor Expression In Vivo: Role of Nitric Oxide Circulation, December 10, 2002; 106(24): 3120 - 3125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. T. Jantzen, K. E. Connor, G. DiCarlo, G. L. Wenk, J. L. Wallace, A. M. Rojiani, D. Coppola, D. Morgan, and M. N. Gordon Microglial Activation and beta -Amyloid Deposit Reduction Caused by a Nitric Oxide-Releasing Nonsteroidal Anti-Inflammatory Drug in Amyloid Precursor Protein Plus Presenilin-1 Transgenic Mice J. Neurosci., March 15, 2002; 22(6): 2246 - 2254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Liu, J. E. Saavedra, T. Lu, J.-G. Song, J. Clark, M. P. Waalkes, and L. K. Keefer O2-Vinyl 1-(Pyrrolidin-1-yl)diazen-1-ium-1,2-diolate Protection Against D-Galactosamine/Endotoxin-Induced Hepatotoxicity in Mice: Genomic Analysis Using Microarrays J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 18 - 25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Fiorucci, A. Mencarelli, B. Palazzetti, E. Distrutti, N. Vergnolle, M. D. Hollenberg, J. L. Wallace, A. Morelli, and G. Cirino Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis PNAS, November 20, 2001; 98(24): 13936 - 13941. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Fiorucci, E. Distrutti, M. N. Ajuebor, A. Mencarelli, R. Mannucci, B. Palazzetti, P. Del Soldato, A. Morelli, and J. L. Wallace NO-mesalamine protects colonic epithelial cells against apoptotic damage induced by proinflammatory cytokines Am J Physiol Gastrointest Liver Physiol, September 1, 2001; 281(3): G654 - G665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Ignarro, G. M. Buga, L. H. Wei, P. M. Bauer, G. Wu, and P. del Soldato Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation PNAS, March 16, 2001; (2001) 71054698. [Abstract] [Full Text]
|
|
|
|
|
|
L. J. Ignarro, G. M. Buga, L. H. Wei, P. M. Bauer, G. Wu, and P. del Soldato Inaugural Article: Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation PNAS, March 27, 2001; 98(7): 4202 - 4208. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
